Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NUDT11 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | IGFL2 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
mRNA | ELOVL2 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | ST14 | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
mRNA | RYR3 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
mRNA | ZBTB17 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | FAM189B | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
mRNA | FAM151A | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
mRNA | FMO4 | FIMM | pan-cancer | AAC | -0.44 | 0.008 |
mRNA | RECQL5 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |